{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:16:13Z","timestamp":1789809373192,"version":"4.0.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"national research foundation of south africa"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0173352","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T18:39:53Z","timestamp":1489084793000},"page":"e0173352","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice"],"prefix":"10.1371","volume":"12","author":[{"given":"Ros","family":"Chapman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsungai Ivai","family":"Jongwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Chege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"ref1","unstructured":"AIDS by the numbers 2016. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/AIDS-by-the-numbers-2016_en.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/AIDS-by-the-numbers-2016_en.pdf<\/ext-link>."},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/mt.2015.210","article-title":"Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition","volume":"24","author":"S Abdul-Jawad","year":"2016","journal-title":"Mol Ther"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"DH Barouch","year":"2010","journal-title":"Nat Med"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2013.09.061","article-title":"Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys","volume":"155","author":"DH Barouch","year":"2013","journal-title":"Cell"},{"issue":"4","key":"ref5","first-page":"282","article-title":"Mosaic Vaccines Elicit Cd8+T Cell Responses in Monkeys That Confer Immune Coverage of Diverse Hiv Strains","volume":"39","author":"S Santra","year":"2010","journal-title":"J Med Primatol"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.4049\/jimmunol.1004231","article-title":"Mosaic HIV-1 Gag Antigens Can Be Processed and Presented to Human HIV-Specific CD8(+) T Cells","volume":"186","author":"ZM Ndhlovu","year":"2011","journal-title":"J Immunol"},{"issue":"23","key":"ref7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"New Engl J Med"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"DR Casimiro","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.vaccine.2015.11.062","article-title":"Prime-boost vaccine strategy against viral infections: Mechanisms and benefits","volume":"34","author":"K Kardani","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/JVI.79.2.771-779.2005","article-title":"Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins","volume":"79","author":"JR Mascola","year":"2005","journal-title":"J Virol"},{"issue":"25","key":"ref11","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.vaccine.2008.02.072","article-title":"EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone","volume":"26","author":"S McCormack","year":"2008","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"51-422X","DOI":"10.1186\/1743-422X-8-51","article-title":"The porcine circovirus type 1 capsid gene promoter improves antigen expression and immunogenicity in a HIV-1 plasmid vaccine","volume":"8","author":"FL Tanzer","year":"2011","journal-title":"Virology journal"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/14760584.2016.1129904","article-title":"Justification for the inclusion of Gag in HIV vaccine candidates","volume":"15","author":"AL Williamson","year":"2016","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CVI.00717-15","article-title":"Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap","volume":"23","author":"GE Gray","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"e0159141","DOI":"10.1371\/journal.pone.0159141","article-title":"HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice","volume":"11","author":"TI Jongwe","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0264-410X(97)00296-X","article-title":"DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice","volume":"16","author":"T Hanke","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/088922203762688649","article-title":"Characterization and selection of HIV-1 subtype C isolates for use in vaccine development","volume":"19","author":"C Williamson","year":"2003","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2007.01.035","article-title":"Structural and biochemical studies of ALIX\/AIP1 and its role in retrovirus budding","volume":"128","author":"RD Fisher","year":"2007","journal-title":"Cell"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"e71601","DOI":"10.1371\/journal.pone.0071601","article-title":"Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice","volume":"8","author":"R Chapman","year":"2013","journal-title":"PLoS One"},{"issue":"Pt 2","key":"ref20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/vir.0.81379-0","article-title":"Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial","volume":"87","author":"WA Burgers","year":"2006","journal-title":"J Gen Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cacc.2006.03.005","article-title":"Multiple comparisons","volume":"17","author":"MO Columb","year":"2006","journal-title":"Current Anaesthesia & Critical Care"},{"issue":"7","key":"ref22","article-title":"HIV-1 Assembly, Budding, and Maturation","volume":"2","author":"WI Sundquist","year":"2012","journal-title":"Csh Perspect Med"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/JVI.02061-15","article-title":"Dimerization of the SP1 Region of HIV-1 Gag Induces a Helical Conformation and Association into Helical Bundles: Implications for Particle Assembly","volume":"90","author":"SAK Datta","year":"2016","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1099\/vir.0.19525-0","article-title":"Influence of flanking sequences on presentation efficiency of a CD8(+) cytotoxic T-cell epitope delivered by parvovirus-like particles","volume":"85","author":"P Rueda","year":"2004","journal-title":"Journal of General Virology"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/JVI.80.10.4717-4728.2006","article-title":"Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 gag coupled to CD8(+) T-cell epitopes","volume":"80","author":"N Goonetilleke","year":"2006","journal-title":"J Virol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118486","article-title":"Potent Functional Antibody Responses Elicited by HIV-I DNA Priming and Boosting with Heterologous HIV-1 Recombinant MVA in Healthy Tanzanian Adults","volume":"10","author":"A Joachim","year":"2015","journal-title":"Plos One"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"F Saade","year":"2012","journal-title":"Expert Review of Vaccines"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20071331","article-title":"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","volume":"205","author":"A Harari","year":"2008","journal-title":"J Exp Med"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8(+) T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/JVI.03135-15","article-title":"Potential To Streamline Heterologous DNA Prime and NYVAC\/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens","volume":"90","author":"B Asbach","year":"2016","journal-title":"J Virol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virol.2005.06.014","article-title":"Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA\/MVA vaccines expressing mature and immxature VLPs","volume":"340","author":"D Ellenberger","year":"2005","journal-title":"Virology"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1089\/aid.2004.20.1335","article-title":"DNA\/MVA vaccine for HIV type 1: Effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime","volume":"20","author":"JM Smith","year":"2004","journal-title":"Aids Research and Human Retroviruses"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0173352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T05:26:05Z","timestamp":1540358765000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0173352"}},"subtitle":[],"editor":[{"given":"Shixia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0173352","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]}}}